Inventor · disambiguated record
Michael Anthony Marella
Also filed as: MARELLA MICHAEL · MARELLA MICHAEL A · MARELLA MICHAEL ANTHONY
33 granted patents·13 pending applications·548 citations·filing 1997–2024
97Inventor score
Files withADOLOR CORP20WYETH CORP14EXXONMOBIL TECHNOLOGY & ENGINEERING COMPANY4WYETH LLC4EXXONMOBIL RES & ENG CO3
Top patents by PatentIndex Score
46 records- 0197US7317037B2Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereofWYETH CORP·Filed 2005·Granted Jan 8, 2008·69 cites·37 claims
- 0294US9346738B2Process for the preparation of treprostinil and derivatives thereofSCIPHARM SÀRL·Filed 2013·Granted May 24, 2016·44 cites·17 claims
- 0394US6486165B2Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewithADOLOR CORP·Filed 2001·Granted Nov 26, 2002·43 cites·2 claims
- 0493US10252918B2EMM-28, a novel synthetic crystalline material, its preparation and useEXXONMOBIL RES & ENG CO·Filed 2016·Granted Apr 9, 2019·7 cites·18 claims
- 0592US6492351B1Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewithADOLOR CORP·Filed 2001·Granted Dec 10, 2002·24 cites·1 claims
- 0692US5688955AKappa agonist compounds and pharmaceutical formulations thereofADOLOR CORP·Filed 1997·Granted Nov 18, 1997·66 cites·15 claims
- 0788US6057323AKappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewithADOLOR CORP·Filed 1998·Granted May 2, 2000·38 cites·2 claims
- 0887US5763445AKappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewithADOLOR CORP·Filed 1997·Granted Jun 9, 1998·49 cites·3 claims
- 0986US7517899B2Phenylaminopropanol derivatives and methods of their useWYETH CORP·Filed 2005·Granted Apr 14, 2009·9 cites·28 claims
- 1085US7618990B2Oxazolidone derivatives as PR modulatorsWYETH CORP·Filed 2007·Granted Nov 17, 2009·9 cites·24 claims
- 1185US2025025854A1Emm-41 composition, methods of making and uses thereofEXXONMOBIL TECHNOLOGY & ENGINEERING COMPANY·Filed 2024·Application pending·0 cites
- 1285US2025025855A1Emm-41 composition, methods of making and uses thereofEXXONMOBIL TECHNOLOGY & ENGINEERING COMPANY·Filed 2024·Application pending·0 cites
- 1383US10710889B2EMM-31 materials and processes and uses thereofEXXONMOBIL RES & ENG CO·Filed 2018·Granted Jul 14, 2020·1 cites·29 claims
- 1480US5981513AKappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewithADOLOR CORP·Filed 1998·Granted Nov 9, 1999·30 cites·6 claims
- 1579US5744458AKappa agonist compounds and pharmaceutical formulations thereofADOLOR CORP·Filed 1997·Granted Apr 28, 1998·36 cites·15 claims
- 1677US6303611B1Kappa agonist compounds and pharmaceutical formulations thereofADOLOR CORP·Filed 1998·Granted Oct 16, 2001·38 cites·5 claims
- 1776US7601722B2Aryl sulfamide derivatives and methods of their useWYETH CORP·Filed 2007·Granted Oct 13, 2009·2 cites·58 claims
- 1874US7723332B2Aryl sulfonamides useful for modulation of the progesterone receptorWYETH LLC·Filed 2008·Granted May 25, 2010·1 cites·13 claims
- 1973US12466738B2Intramolecular pi-stacking structure directing agents and molecular sieves synthesized therefromEXXONMOBIL TECHNOLOGY & ENGINEERING COMPANY·Filed 2020·Granted Nov 11, 2025·0 cites·13 claims
- 2073US12161990B2EMM-41 composition, methods of making and uses thereofEXXONMOBIL TECHNOLOGY & ENGINEERING COMPANY·Filed 2019·Granted Dec 10, 2024·0 cites·9 claims
- 2172US6391910B1Kappa agonist compounds and pharmaceutical formulations thereofADOLOR CORP·Filed 2000·Granted May 21, 2002·5 cites·5 claims
- 2268US10597300B2EMM-28, a novel synthetic crystalline material, its preparation and useEXXONMOBIL RES & ENG CO·Filed 2019·Granted Mar 24, 2020·0 cites·16 claims
- 2368US6028063AKappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewithADOLOR CORP·Filed 1999·Granted Feb 22, 2000·15 cites·3 claims
- 2467US7294647B2Kappa agonist compounds and pharmaceutical formulations thereofADOLOR CORP·Filed 2003·Granted Nov 13, 2007·1 cites·4 claims
- 2567US6180623B1Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewithADOLOR CORP·Filed 1999·Granted Jan 30, 2001·14 cites·8 claims
- 2662US6054445AKappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritis therewithADOLOR CORP·Filed 1999·Granted Apr 25, 2000·20 cites·1 claims
- 2762US2009093469A1Phenylaminopropanol Derivatives and Methods of Their UseWYETH CORP·Filed 2008·Application pending·0 cites
- 2862US2009099164A1Phenylaminopropanol Derivatives and Methods of Their UseWYETH CORP·Filed 2008·Application pending·0 cites
- 2960US6750216B2Kappa agonist compounds and pharmaceutical formulations thereofADOLOR CORP·Filed 2002·Granted Jun 15, 2004·1 cites·9 claims
- 3060US2010029641A1Aryl sulfamide derivatives and methods of their useWYETH CORP·Filed 2009·Application pending·0 cites
- 3159USRE38133EKappa agonist compounds and pharmaceutical formulations thereofADOLOR CORP·Filed 2002·Granted Jun 3, 2003·1 cites·15 claims
- 3258US5945443AKappa agonist compounds and pharmaceutical formulations thereofADOLOR CORP·Filed 1998·Granted Aug 31, 1999·14 cites·15 claims
- 3357US6960612B2Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewithADOLOR CORP·Filed 2003·Granted Nov 1, 2005·0 cites·4 claims
- 3456US2008114050A1Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereofWYETH CORP·Filed 2007·Application pending·0 cites
- 3554US6239154B1Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewithADOLOR CORP·Filed 1999·Granted May 29, 2001·11 cites·2 claims
- 3652US2002042399A1Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewithADOLOR CORP·Filed 2001·Application pending·0 cites
- 3750US2005020576A1Kappa agonist compounds and pharmaceutical formulations thereofADOLOR CORP·Filed 2004·Application pending·0 cites
- 3849US7538107B2Oxazinan-2-one derivatives useful as PR modulatorsWYETH CORP·Filed 2007·Granted May 26, 2009·0 cites·22 claims
- 3948US7652018B2Imidazolidin-2-one derivatives useful as PR modulatorsWYETH LLC·Filed 2007·Granted Jan 26, 2010·0 cites·17 claims
- 4048US7649007B2Oxazolidine derivatives as PR modulatorsWYETH LLC·Filed 2007·Granted Jan 19, 2010·0 cites·20 claims
- 4148US7618989B2Tricyclic oxazolidone derivatives useful as PR modulatorsWYETH CORP·Filed 2007·Granted Nov 17, 2009·0 cites·19 claims
- 4247US2008045560A1Pyrrolidine and related derivatives useful as PR modulatorsWYETH CORP·Filed 2007·Application pending·0 cites
- 4344US2010204228A1Aryl Sulfonamides Useful for Modulation of the Progesterone ReceptorWYETH LLC·Filed 2010·Application pending·0 cites
- 4444US2007072897A1Phenylaminopropanol derivatives and methods of their useWYETH CORP·Filed 2006·Application pending·0 cites
- 4543US2006030615A1Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereofWYETH CORP·Filed 2005·Application pending·0 cites
- 4642US2006009509A1Progesterone receptor antagonists, contraceptive regimens, and kitsWYETH CORP·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →